Tag : PREVENTIVE PERCUTANEOUS CORONARY INTERVENTION
Patients with intracoronary imaging-defined vulnerable plaques (VP) have a higher risk of experiencing major adverse cardiac events. While optimal medical therapy (OMT) is the standard approach to stabilize plaque vulnerability, the effectiveness and safety of focal preventive percutaneous coronary intervention (PCI) have not been established. At the ACC Annual Scientific Session 2024, Professor Seung-Jung Park from the University of Ulsan College of Medicine, Seoul, South Korea, presented results from the PREVENT trial, which aimed to assess whether focal preventive PCI of non-flow-limiting imaging-defined VPs improves clinical outcomes compared to OMT alone.